Acumen pharmaceuticals to hold conference call to discuss positive topline results from first-in-human phase 1 study of acu193 for early alzheimer's disease

Company to host conference call and webcast for investors and analysts today, july 17, at 8 a.m. et company to host conference call and webcast for investors and analysts today, july 17, at 8 a.m. et

ABOS Ratings Summary

ABOS Quant Ranking